DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies

Journal of Virology

Volumn 72, Issue 9, 1998, Pages 7310-7319

  Hosie, Margaret J ^a   Flynn, J Norman ^a   Rigby, Mark A ^a   Cannon, Celia ^a   Dunsford, Thomas ^a   Mackay, Nancy A ^a   Argyle, David ^a   Willett, Brian J ^a   Miyazawa, Takayuki ^a,b   Onions, David E ^a   Jarrett, Oswald ^a   Neil, James C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FELINE IMMUNODEFICIENCY VIRUS; GENE DELETION; IMMUNE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MONONUCLEAR CELL; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS INDUCTION; VIRUS INFECTION; VIRUS LOAD;

EID: 0031846231     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.9.7310-7319.1998     Document Type: Article

References (49)

1. Argyle, D. J., K. Smith, K. McBride, R. Fulton, and D. E. Onions. 1995. Nucleotide and predicted peptide sequence of feline interferon-gamma (IFN-gamma). DNA Sequence 5:169-171.
2. Avrameas, A., A. D. Strosberg, A. Moraillon, P. Sonigo, and G. Pancino. 1993. Serological diagnosis of feline immunodeficiency virus (FIV) infection based on synthetic peptides from Env glycoproteins. Res. Virol. 144:209-218.
3. Baba, T. W., Y. S. jeong, D. Penninck, R. Bronson, M. F. Greene, and R. M. Ruprecht. 1995. Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820-1825.
4. Boyer, J. D., K. E. Ugen, B. Wang, M. Agadjanyan, L. Gilbert, M. L. Bagarazzi, M. Chattergoon, P. Frost, A. Javadian, W. Williams, Y. Refaeli, R. B. Ciccarelli, D. McCallus, L. Coney, and D. B. Weiner. 1997. Protection of chimpanzees from high dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3:526-532.
5. Crandell, R. A., C. G. Fabricant, and W. A. Nelson-Rees. 1973. Development, characterisation and virus susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro 9:176-185.
6. Daniel, M. D., F. Kirchhoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
7. Diehl, L. J., C. K. Mathiason-DuBard, L. L. O'Neil, L. Obert, and E. A. Hoover. 1995. Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J. Virol. 69:6149-6157.
8. Fauci, A. S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogencsis. Science 239:617-622.
9. Flynn, J. N., J. A. Beatty, C. A. Cannon, E. B. Stephens, M. J. Hosie, J. C. Neil, and O. Jarrett. 1995. Involvement of gag-and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res. Hum. Retroviruses 11:1107-1113.
10. Flynn, J. N., C. A. Cannon, G. Reid, M. A. Rigby, J. C. Neil, and O. Jarrett. 1995. Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenie peptide from the envelope V3 domain. Immunology 85:171-175.
11. Flynn, J. N., P. Keating, M. J. Hosie, M. Mackett, E. B. Stephens, J. A. Beatty, J. C. Neil, and O. Jarrett. 1996. Env-specific CTL predominate in cats protected from FIV infection by vaccination. J. Immunol. 157:3658-3665.
12. Fontenot, J. D., E. A. Hoover, J. H. Elder, and R. C. Montelaro. 1993 Evaluation of feline immunodeficiency virus and feline leukaemia virus transmembrane peptides for serological diagnosis. J. Clin. Microbiol. 30: 1885-1890.
13. Gerdts, V., A. Jons, B. Makoschey, N. Visser, and T. C. Mettenleiter. 1997 Protection of pigs against Aujeszky's disease by DNA vaccination. J. Gen Virol. 78:2139-2146.
14. Giavedoni, L., S. Ahmad, L. Jones, and T. Yilma. 1997. Expression of gamma-interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. J. Virol. 71; 866-872.
15. Holyoake, T. L. 1996. Cytokines at the research-clinical interface-potential applications. Blood Rev. 10:189-200.
16. Hosie, M., R. Osborne, J. K. Yamamoto, J. C. Neil, and O. Jarrett. 1995. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J. Virol. 69:1253-1255.
17. Hosie, M. J., T. H. Dunsford, A. de Ronde, B. J. Willett, C. A. Cannon, J. C, Neil, and O. Jarrett. 1996. Suppression of virus burden by immunisation with feline immunodeficiency virus Env protein. Vaccine 14:405-411.
18. Hosie, M. J., and J. N. Flynn. 1996. Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection. J. Virol. 70: 7561-7568.
19. Hosie, M. J., and O. Jarrett. 1990. Serological responses of cats to feline immunodeficiency virus. AIDS 4:215-220.
20. Hosie, M. J., R. Osborne, G. Reid, J. C. Neil, and O. Jarrett. 1992. Enhancement after feline immunodeficiency virus vaccination. Vet. Immunol. Immunopathol. 35:191-198.
21. Hosie, M. J., B. J. Willett, T. H. Dunsford, C. A. Robertson, C. A. Cannon, J. C. Neil, and O. Jarrett. Unpublished data.
22. Israel, Z. R., P. F. Edmonson, D. H. Maul, S. P. O'Neil, S. P. Mossman, C. Thiriart, L. Fabry, O. Van Opstal, C. Bruck, F. Bex, A. Burny, P. N. Fultz, J. I. Mullins, and E. A. Hoover. 1994. Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines, J. Virol. 68:1843-1853.
23. Khatissian, E., V. Monceaux, M. C. Cumont, L. Montagnier, B. Hurtrel, and L. Chakrabarti. 1996. Interferon-gamma expression in macaque lymph nodes during primary infection with simian immunodeficiency virus. Cytokine 8:844-852.
24. Lu, S., J. Arthos, D. C. Montefiori, Y. Yasutomi, K. Manson, F. Mustafa, E. Johnson, J. C. Santoro, J. Wissink, J. I. Mullins, J. K. Haynes, N. L. Letvin, M. Wyand, and H. L. Robinson. 1996. Simian immunodeficiency virus-DNA vaccine trial in macaques. J. Virol. 70:3978-3991.
25. Lu, S., J. C. Santoro, D. H. Fuller, J. R. Haynes, and H. L. Robinson. 1995. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody-responses in mice. Virology 209:147-154.
26. McCullagh, P., and J. A. Nelder. 1989. Generalized linear models, p. 11-12. Chapman & Hall, London, United Kingdom.
27. Miyazawa, T. M., T. Furuya, S. Itagaki, Y. Tohya, E. Takahashi, and T. Mikami. 1989. Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch. Virol. 108: 131-135.
28. Olmsted, R. A., V. M. Hirsch, R. H. Purcell, and P. R. Johnson. 1989. Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proc. Natl. Acad. Sci. USA 86:8088-8092.
29. Osborne, R., M. Rigby, K. Siebelink, J. C. Neil, and O. Jarrett. 1994. Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J. Gen. Virol. 75:3641-3645.
30. Pancino, G., C. Chappey, W. Saurin, and P. Sonigo. 1993. B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins. J. Virol. 67:664-672.
31. Richardson, J., A. Moraillon, S. Baud, A.-M. Cuisinier, P. Sonigo, and G. Pancino. 1997. Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J. Virol. 71:9640-9649.
32. Rigby, M. A., M. J. Hosie, B. J. Willett, N. Mackay, M. McDonald, C. Cannon, T. Dunsford, O. Jarrett, and J. C. Neil. 1997. Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation. AIDS Res. Hum. Retroviruses 13:405-412.
33. Robinson, H. L., L. A. Hunt, and R. G. Webster. 1993. Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine 11:957-960.
34. Robinson, H. L., S. Lu, F. Mustafa, E. Johnson, J. C. Santoro, J. Arthos, J. Winsink, J. I. Mullins, D. Montefiori, Y. Yasutomi, N. L. Letvin, J. R. Haynes, K. Manson, and M. Wyand. 1995. Simian immunodeficiency virus-DNA vaccine trial in macaques. Ann. N.Y. Acad. Sci. 772:209-211.
35. Rowland-Jones, S. L., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schulz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
36. Sakaguchi, M., H. Nakamura, K. Sonoda, F. Hamamda, and K. Hirai. 1996. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine 14:747-752.
37. Shearer, G. M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17:21-24.
38. Shiver, J. W., M. E. Davies, H. C. Perry, D. C. Freed, and M. A. Liu. 1996. Humoral and cellular immunities elicited by HIV-1 DNA vaccination. J. Pharm. Sci. 85:1317-1324.
39. Sibille, P., A. Avrameas, A. Moraillon, J. Richardson, P. Sonigo, G. Pancino, and A. D. Strosberg. 1995. Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats. Vet. Microbiol. 45:259-267.
40. Siebelink, K. H. J., E. Tijhaar, R. C. Huisman, W. Huisman, A. de Ronde, I. H. Darby, M. J. Francis, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus. 1995. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J. Virol. 69:3704-3711.
41. Stephens, E. B., E. J. Butliloski, and E. Monck. 1992. Analysis of the amino terminal presequence of the feline immunodeficiency virus glycoprotein: effect of deletions on the intracellular transport of gp95. Virology 190:569-578.
42. Ulmer, J. B., J. C. Sadoff, and M. A. Liu. 1996. DNA vaccines. Curr. Opin. Immunol. 8:531-536.
43. Wang, B., J. Boyer, V. Srikantan, L. Coney, R. Carrano, C. Phan, M. Merva, K. Dang, M. Agadjanan, L. Gilbert, K. E. Ugen, W. V. Williams, and D. B. Weiner. 1993. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type-1 in mice and non-human primates. DNA Cell Biol. 12:799-805.
44. Willett, B., M. J. Hosie, T. Dunsford, J. C. Neil, and O. Jarrett. 1991. Productive infection of helper T lymphocytes with FIV is accompanied by reduced expression of CD4. AIDS 5:1469-1475.
45. Willett, B. J., J. N. Flynn, and M. J. Hosie. 1997. FIV infection of the domestic cat: an animal model for AIDS. Immunol. Today 18:182-189.
46. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.
47. Yamamoto, J. K., C. D. Ackley, H. Zochlinski, H. Louie, E. Pembroke, M. Torten, H. Hansen, R. Munn, and T. Okuda. 1991. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency viruses: importance for diagnostic reagents and vaccines. Intervirology 32:361-375.
48. Yamamoto, J. K., T. Okuda, C. D. Ackley, H. Louie, E. Pembroke, H. Zochlinski, R. J. Munn, and M. B. Gardner. 1991. Experimental vaccine protection against feline immunodeficiency virus. AIDS Res. Hum. Retroviruses 7:911-921.
49. Yasutomi, Y., H. L. Robinson, S. Lu, F. Mustafa, C. Lekutis, J. Arthos, J. I. Mullins, G. Voss, K. Manson, M. Wyand, and N. L. Letvin. 1996. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 70:678-681.